Filing Details
- Accession Number:
- 0001398344-25-007139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-15 12:22:43
- Reporting Period:
- 2025-02-25
- Filing Date:
- 2025-04-15
- Accepted Time:
- 2025-04-15 12:22:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588217 | Jad Fakhry | 330 Primrose Road, Suite 400 Burlingame CA 94010 | No | No | Yes | No | |
| 1588273 | Poplar Point Capital Management Llc | 330 Primrose Road, Suite 400 Burlingame CA 94010 | No | No | Yes | No | |
| 1588288 | Poplar Point Capital Gp Llc | 330 Primrose Road, Suite 400 Burlingame CA 94010 | No | No | Yes | No | |
| 1588289 | Poplar Point Capital Partners Lp | 330 Primrose Road, Suite 400 Burlingame CA 94010 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-25 | 25,033 | $0.62 | 730,205 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-26 | 6,302 | $0.61 | 736,507 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-27 | 385 | $0.61 | 736,892 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-28 | 13,108 | $0.60 | 750,000 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-03-04 | 4,000 | $0.58 | 754,000 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-03-07 | 102 | $0.55 | 754,102 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This Form 4 is being jointly filed by Poplar Point Capital Partners LP ("PPCP"), Poplar Point Capital Management LLC ("PPCM"), Poplar Point Capital GP LLC ("PPCGP"), and Mr. Jad Fakhry (collectively with PPCP, PPCM and PPCGP, the "Reporting Persons") with respect to shares of common stock of the above named issuer owned by PPCP. PPCM is the investment manager of PPCP. PPCGP is the general partner of PPCP. Mr. Fakhry is the manager of PPCM and PPCGP, and owns a controlling interest in, PPCM and PPCGP. The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).
Billionaire Hedge Funds
